InflaRx N.V. (IFRX) shareholders
IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 5/30
$1.15−0.03 (-2.54%)
Close on Nov 17, 2026Market cap $83.14MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
97M of 72M shares
Institutional holders
62
30 new, 3 sold out
Net institutional buying
78M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Montanova Capital, LLC Joint filing with Aaron Cowen (15.60%), Averill Master Fund, Ltd. (12.50%) | 22,933,910 | 15.60% | 13G (passive) amendment | Jun 30, 2026 |
| TCG Crossover GP III, LLC Joint filing with TCG Crossover Fund III, L.P. (9.80%), Chen Yu (9.80%) | 14,500,000 | 9.80% | 13G (passive) | May 7, 2026 |
| Alex Silverstein Joint filing with Sirenia Capital Management LP (6.10%) | 8,911,348 | 6.10% | 13G (passive) | Jun 30, 2026 |
| FMR LLC Joint filing with Abigail P. Johnson (5.50%) | 8,163,341 | 5.50% | 13G (passive) | Jun 30, 2026 |
| Suvretta Capital Management, LLC Joint filing with Aaron Cowen (11.70%), Averill Master Fund, Ltd. (11.40%) | 7,933,910 | 11.70% | 13G (passive) amendment | Dec 31, 2025 |
| Wehrly, Mark C. Joint filing with Warren, John R. (5.10%), Dapice Joshua J. (5.10%) and 13 more | 7,500,000 | 5.10% | 13G (passive) | May 7, 2026 |
| Commodore Capital LP Joint filing with Commodore Capital Master LP (5.10%), Robert Egen Atkinson (5.10%) and 1 more | 7,475,000 | 5.10% | 13G (passive) | Aug 10, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of IFRX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 22,933,910 | 31.72% | $51.37M | +15,000,000 | 0.94% |
| TCG Crossover Management, LLC | 14,500,000 | 20.06% | $32.48M | New | 0.78% |
| FMR LLC | 8,163,341 | 11.29% | $18.29M | New | 0.00% |
| Commodore Capital LP | 7,300,000 | 10.10% | $16.35M | New | 0.97% |
| Kalehua Capital Management LLC | 5,795,538 | 8.02% | $12.98M | New | 4.14% |
| Spruce Street Capital LP | 5,352,198 | 7.40% | $11.99M | New | 2.35% |
| 683 Capital Management, LLC | 5,065,000 | 7.01% | $11.35M | +1,750,000 | 0.56% |
| Farallon Capital Management LLC | 3,325,000 | 4.60% | $7.45M | New | 0.03% |
| Stempoint Capital LP | 3,228,255 | 4.47% | $7.23M | New | 1.25% |
| Great Point Partners LLC | 3,046,557 | 4.21% | $6.82M | New | 1.29% |
| ADAR1 Capital Management, LLC | 3,000,000 | 4.15% | $6.72M | +2,841,729 | 0.31% |
| Ameriprise Financial Inc | 2,572,799 | 3.56% | $5.76M | New | 0.00% |
| Woodline Partners LP | 2,105,486 | 2.91% | $4.72M | New | 0.01% |
| Squadron Capital Management LLC | 2,000,000 | 2.77% | $4.48M | New | 1.39% |
| Eversept Partners, LP | 1,304,069 | 1.80% | $2.92M | −454,504 | 0.15% |
| Franklin Resources Inc | 1,036,118 | 1.43% | $2.32M | New | 0.00% |
| Morgan Stanley | 915,614 | 1.27% | $2.05M | −259,962 | 0.00% |
| Jefferies Financial Group Inc. | 775,349 | 1.07% | $1.74M | New | 0.01% |
| Marshall Wace, Llp | 711,296 | 0.98% | $1.59M | +156,932 | 0.00% |
| Millennium Management LLC | 567,049 | 0.78% | $1.27M | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 62 | 97M | 100.0% | 30 / 13 | 8 / 3 | 81M | 3M |
| Q1 2026 | 35 | 19M | 26.1% | 7 / 7 | 9 / 6 | 1M | 1M |
| Q4 2025 | 34 | 19M | 26.8% | 13 / 11 | 5 / 6 | 5M | 4M |
| Q3 2025 | 27 | 19M | 25.7% | 8 / 6 | 5 / 8 | 4M | 2M |
| Q2 2025 | 27 | 17M | 23.3% | 9 / 6 | 8 / 13 | 4M | 4M |
| Q1 2025 | 31 | 18M | 24.2% | 11 / 7 | 6 / 10 | 6M | 2M |
| Q4 2024 | 30 | 13M | 18.1% | 9 / 8 | 6 / 4 | 3M | 2M |
| Q3 2024 | 27 | 13M | 17.9% | 4 / 4 | 8 / 10 | 0M | 1M |
| Q2 2024 | 33 | 13M | 18.3% | 4 / 8 | 9 / 8 | 2M | 5M |
| Q1 2024 | 37 | 16M | 21.9% | 7 / 12 | 7 / 9 | 2M | 4M |
| Q4 2023 | 39 | 18M | 25.0% | 5 / 11 | 14 / 8 | 3M | 4M |
| Q3 2023 | 42 | 19M | 26.4% | 10 / 15 | 8 / 5 | 2M | 1M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Renfeng Guo | Chief Scientific Officer, Director | 1,762,144 | 2.44% | Mar 18, 2026 |
| Niels Riedemann | Chief Executive Officer, Director | 1,068,908 | 1.48% | Mar 18, 2026 |
| Thomas Taapken | Chief Financial Officer | 3,500 | 0.00% | Mar 18, 2026 |
| Derval OCarroll | See Remarks | – | – | Mar 18, 2026 |
| Mark Kubler | Director | 960,015 | 1.33% | Mar 18, 2026 |
| Nicolas Fulpius | Director | 490,052 | 0.68% | Mar 18, 2026 |
| Hege Hellstrom | Director | – | – | Mar 18, 2026 |
| Anthony S. Gibney | Director | 10,000 | 0.01% | Mar 18, 2026 |
| Richard Brudnick | Director | 50,000 | 0.07% | Mar 18, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
13M shares short
Days to cover
15.0
At 1M shares a day
Change since last report
+0.9%
From 13M shares
Short volume, 20 days
35.6%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of InflaRx's stock actually held short. Settlement fails (shares not delivered on time) peaked at 172,480 shares on Oct 13, 2026 over the last 90 days.
See a number that looks wrong?